This company listing is no longer active
Mithra Pharmaceuticals Toekomstige groei
Future criteriumcontroles 5/6
Er wordt voorspeld dat Mithra Pharmaceuticals de winst en omzet met respectievelijk 100.7% en 43.1% per jaar zal laten groeien.
Belangrijke informatie
100.7%
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 15.4% |
Inkomstengroei | 43.1% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 06 May 2024 |
Recente toekomstige groei-updates
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 137 | 44 | N/A | N/A | 1 |
12/31/2025 | 96 | 14 | N/A | N/A | 1 |
12/31/2024 | 44 | -55 | N/A | N/A | 1 |
12/31/2023 | 40 | -174 | -2 | -2 | N/A |
9/30/2023 | 51 | -126 | -15 | -6 | N/A |
6/30/2023 | 63 | -79 | -28 | -9 | N/A |
3/31/2023 | 65 | -69 | -55 | -33 | N/A |
12/31/2022 | 67 | -60 | -82 | -57 | N/A |
9/30/2022 | 44 | -76 | -92 | -68 | N/A |
6/30/2022 | 22 | -93 | -102 | -78 | N/A |
3/31/2022 | 22 | -105 | -100 | -78 | N/A |
12/31/2021 | 23 | -117 | -98 | -77 | N/A |
9/30/2021 | 21 | -115 | -94 | -75 | N/A |
6/30/2021 | 19 | -113 | -91 | -73 | N/A |
3/31/2021 | 14 | -103 | -94 | -77 | N/A |
12/31/2020 | 9 | -92 | -96 | -80 | N/A |
9/30/2020 | 44 | -31 | -85 | -70 | N/A |
6/30/2020 | 79 | 29 | -73 | -59 | N/A |
3/31/2020 | 88 | 1 | -68 | -53 | N/A |
12/31/2019 | 97 | -27 | -62 | -47 | N/A |
9/30/2019 | 84 | -54 | -42 | -28 | N/A |
6/30/2019 | 71 | -82 | -21 | -5 | N/A |
3/31/2019 | 64 | -55 | -14 | -1 | N/A |
12/31/2018 | 58 | -28 | -7 | 4 | N/A |
9/30/2018 | 46 | -41 | -23 | -9 | N/A |
6/30/2018 | 33 | -53 | -40 | -25 | N/A |
3/31/2018 | 33 | -46 | -44 | -28 | N/A |
12/31/2017 | 32 | -38 | -47 | -31 | N/A |
9/30/2017 | 26 | -37 | N/A | -32 | N/A |
6/30/2017 | 20 | -36 | N/A | -32 | N/A |
3/31/2017 | 21 | -36 | N/A | -28 | N/A |
12/31/2016 | 22 | -35 | N/A | -23 | N/A |
9/30/2016 | 21 | -29 | N/A | -23 | N/A |
6/30/2016 | 20 | -23 | N/A | -22 | N/A |
3/31/2016 | 20 | -16 | N/A | -20 | N/A |
12/31/2015 | 20 | -10 | N/A | -18 | N/A |
9/30/2015 | 19 | -9 | N/A | -15 | N/A |
6/30/2015 | 18 | -8 | N/A | -12 | N/A |
3/31/2015 | 19 | -5 | N/A | -6 | N/A |
12/31/2014 | 19 | -3 | N/A | -1 | N/A |
12/31/2013 | 18 | -2 | N/A | 1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat MITRA de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 1.3% ).
Winst versus markt: Er wordt verwacht dat MITRA de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat MITRA binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van MITRA ( 43.1% per jaar) zal naar verwachting sneller groeien dan de markt Belgian ( 7.2% per jaar).
Hoge groei-inkomsten: De omzet van MITRA ( 43.1% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MITRA naar verwachting over 3 jaar hoog zal zijn